Clinical trial / 2011
Low-dose long-chain omega-3 supplements did not improve endothelial function or arterial stiffness.
In a double-blind trial, 312 adults completed 12 months of daily supplementation with 0.45, 0.9, or 1.8 g of n-3 LC-PUFAs or an olive oil placebo. Relative to placebo, mean changes in flow-mediated dilatation were 0.1% (95% CI: -0.9% to 1.1%), -0.3% (-1.3% to 0.6%), and -0.3% (-1.3% to 0.7%), respectively. No significant differences occurred in arterial stiffness or blood pressure across treatment groups.
- Study type
- Randomized controlled trial
- Who was studied
- 312 nonsmoking adults aged 45–70 years
- What was measured
- Flow-mediated dilatation, arterial stiffness, and blood pressure
THE PAPER
Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial.
Sanders TA, Hall WL, Maniou Z, Lewis F, Seed PT, Chowienczyk PJ. Am J Clin Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.